DEMGY Frasne continues its diversification in the medical sector
In issue 283, La Presse Bizontine highlights the strategic development of DEMGY Frasne, an expert in high-precision plastics processing, which is confirming its rise in the medical market in order to diversify its activities and strengthen its position in high value-added applications.
An investment of around €1 million has enabled the production workshop to be completely transformed into a 100% clean room meeting ISO 8 standards, including several production stations and an ISO 7 assembly unit. This move upmarket illustrates DEMGY's desire to meet the growing demands of contractors in the medical device sector.
Historically focused on the automotive industry (which still accounts for 50% of its business), the DEMGY Frasne site is now developing specific and innovative solutions dedicated to medical devices, including the manufacture of microfluidic plates and medical devices for allergists and ophthalmic surgery.
DEMGY Frasne stands out for its ability to manage micro-injection projects from start to finish: choosing the right material, designing and manufacturing injection molds (with precision in the order of tens of microns), producing parts, assembling, packaging if necessary, and delivering. This complete mastery of the value chain is a real asset for its customers.
Through this diversification, DEMGY is confirming its diversified growth strategy, its commitment to sustainable innovation, and its desire to develop its business by opening up to new growth markets.